| Tarangini T. Padhya Md, Pc | |
|
209 E 86th Ct Suite D Merrillville IN 46410-6259 | |
| (219) 736-9042 | |
| (219) 736-9247 |
| Full Name | Tarangini T. Padhya Md, Pc |
|---|---|
| Speciality | Internal Medicine |
| Location | 209 E 86th Ct, Merrillville, Indiana |
| Authorized Official Name and Position | Tarangini T. Padhya (OWNER/PHYSICIAN) |
| Authorized Official Contact | 2197369042 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Tarangini T. Padhya Md, Pc 55 E 86th Ave Po Box 10645 Merrillville IN 46410-6382 Ph: (219) 769-1670 | Tarangini T. Padhya Md, Pc 209 E 86th Ct Suite D Merrillville IN 46410-6259 Ph: (219) 736-9042 |
| NPI Number | 1477734366 |
|---|---|
| Provider Enumeration Date | 11/19/2007 |
| Last Update Date | 02/26/2008 |
| Medicare PECOS PAC ID | 3971687443 |
|---|---|
| Medicare Enrollment ID | O20080221000391 |
News Archive
A team of scientists recently investigated and compared the efficacy of spike-based and nucleocapsid-based COVID-19 vaccines in mice infected with SARS-CoV-2. Their findings reveal that nucleocapsid-based vaccines are effective in preventing SARS-CoV-2 infection in distal organs, such as the brain.
Cystic fibrosis is caused by an inherited mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced that the U.S. Food and Drug Administration has accepted for filing and review the supplemental New Drug Application for SPRYCEL (dasatinib) for the treatment of adult patients with newly diagnosed chronic myeloid leukemia in chronic phase.
As the Covid-19 pandemic resulted in changes to the provision of NHS services, an online platform offering home tests was introduced throughout Wales - enabling service users to access STI testing at home.
SciClone Pharmaceuticals, Inc. today announced a corporate restructuring that will reduce its U.S.-based workforce by approximately 17%, primarily in research and development. This restructuring follows the discontinuation of SciClone's RP101 phase 2 clinical trial announced on October 2, 2009.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477734366 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 01055876 (Indiana) | Primary |
| Provider Name | Tarangini T Padhya |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1588673479 PECOS PAC ID: 3274533146 Enrollment ID: I20061228000345 |
News Archive
A team of scientists recently investigated and compared the efficacy of spike-based and nucleocapsid-based COVID-19 vaccines in mice infected with SARS-CoV-2. Their findings reveal that nucleocapsid-based vaccines are effective in preventing SARS-CoV-2 infection in distal organs, such as the brain.
Cystic fibrosis is caused by an inherited mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced that the U.S. Food and Drug Administration has accepted for filing and review the supplemental New Drug Application for SPRYCEL (dasatinib) for the treatment of adult patients with newly diagnosed chronic myeloid leukemia in chronic phase.
As the Covid-19 pandemic resulted in changes to the provision of NHS services, an online platform offering home tests was introduced throughout Wales - enabling service users to access STI testing at home.
SciClone Pharmaceuticals, Inc. today announced a corporate restructuring that will reduce its U.S.-based workforce by approximately 17%, primarily in research and development. This restructuring follows the discontinuation of SciClone's RP101 phase 2 clinical trial announced on October 2, 2009.
› Verified 7 days ago
News Archive
A team of scientists recently investigated and compared the efficacy of spike-based and nucleocapsid-based COVID-19 vaccines in mice infected with SARS-CoV-2. Their findings reveal that nucleocapsid-based vaccines are effective in preventing SARS-CoV-2 infection in distal organs, such as the brain.
Cystic fibrosis is caused by an inherited mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced that the U.S. Food and Drug Administration has accepted for filing and review the supplemental New Drug Application for SPRYCEL (dasatinib) for the treatment of adult patients with newly diagnosed chronic myeloid leukemia in chronic phase.
As the Covid-19 pandemic resulted in changes to the provision of NHS services, an online platform offering home tests was introduced throughout Wales - enabling service users to access STI testing at home.
SciClone Pharmaceuticals, Inc. today announced a corporate restructuring that will reduce its U.S.-based workforce by approximately 17%, primarily in research and development. This restructuring follows the discontinuation of SciClone's RP101 phase 2 clinical trial announced on October 2, 2009.
› Verified 7 days ago
Uwc- Merrillville Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 616 W 81st Ave Ste A, Merrillville, IN 46410 Phone: 312-421-1016 Fax: 219-255-9588 | |
Solution Telehealth Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2600 W 58th Pl, Merrillville, IN 46410 Phone: 773-732-0816 | |
Northshore Merrillville Pharmacy Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6091 Broadway, Merrillville, IN 46410 Phone: 219-763-8944 Fax: 219-764-5395 | |
Proactive Md Merrillville Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 387 E 84th Dr, Merrillville, IN 46410 Phone: 812-645-1892 | |
Northshore Regional Health Centers Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8555 Taft St, Merrillville, IN 46410 Phone: 219-763-8812 Fax: 219-764-3251 | |
Northshore Regional Health Centers Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 8555 Taft St, Merrillville, IN 46410 Phone: 219-763-8112 Fax: 219-764-3251 | |
Workcare Occupational Health Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 751 E 81st Place, Merrillville, IN 46410 Phone: 219-769-4400 |